eHealth, Inc. Announces Second Quarter 2024 Results
AUSTIN, Texas, Aug. 7, 2024 /PRNewswire/ -- eHealth, Inc. (Nasdaq: EHTH), a leading private online health insurance marketplace, today announced...
AUSTIN, Texas, Aug. 7, 2024 /PRNewswire/ -- eHealth, Inc. (Nasdaq: EHTH), a leading private online health insurance marketplace, today announced...
Q2 2024 and Recent Highlights NEW YORK, Aug. 8, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a...
Second quarter Net Revenue grows 7.3%, Organic Revenue increases 7.8% Updated 2024 guidance reflects sale of majority stake in Insomnia...
CRANFORD, N.J., Aug. 8, 2024 /PRNewswire/ -- Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) ("Citius", "Citius Pharma"), announced today that the U.S....
BERKELEY HEIGHTS, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and...
Second Quarter Highlights Consolidated net sales of $1.39 billion Core net sales of $1.05 billion* GAAP income from continuing operations...
Key Q2 2024 HighlightsFLORHAM PARK, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Conduent (NASDAQ: CNDT), a global technology-led business process...
BOSTON, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based...
HONG KONG, Aug. 7, 2024 /PRNewswire/ -- CLPS Incorporation (the "Company" or "CLPS") (Nasdaq: CLPS) today announced that, through its...
SALT LAKE CITY, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its...
- Proof-of-Concept Phase 2 SHINE Trial Demonstrates ~40% Mean Improvement in ADAS-Cog 11 vs Placebo and Consistent Positive Changes Across...
No Shareholder Action Required at This Time Contacts Investor Relations Contact: Rob Fink FNK IR on behalf of Cognyte Software...
Investigational New Drug (IND) application for CLN-978 in systemic lupus erythematosus (SLE) remains on track to be filed in third...
MINNEAPOLIS, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies...
Financial and Business Highlights WASHINGTON, Aug. 8, 2024 /PRNewswire/ -- Cogent Communications Holdings, Inc. (NASDAQ: CCOI) ("Cogent") today announced service...
SOMERSET, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the “Company”) (Nasdaq: CCLD, CCLDO, CCLDP), a leader in healthcare...
SOMERSET, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the “Company”) (Nasdaq: CCLD, CCLDO, CCLDP), a leader in healthcare...
SOMERSET, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the “Company”) (Nasdaq: CCLD, CCLDO, CCLDP), a leader in healthcare...
Amazon Web Services Alum to Enhance Day-to-Day Operations, Accelerate Innovation and Drive AI Initiatives Contacts CCC Media Contact: Laura Weber...
– Nine patients enrolled as of August 5, 2024 across the RESET™ clinical development program, including four since EULAR in...
HOUSTON, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH) a biotechnology company leveraging its proprietary DNAbilize® antisense...
SUNRISE-PD to evaluate the effect of bezisterim (NE3107) on motor and non-motor symptoms in ~60 patients with Parkinson’s disease who...
- Revenue of $42 million, down 16% Q/Q and up 17% Y/Y - - Gross mining margin of 51%, compared...
Strong quarter with Funded Loan Volume up 45%, Revenue up 41%, and Total Expenses flat in Q2’24 as compared to...
Strong quarter with Funded Loan Volume up 45%, Revenue up 41%, and Total Expenses flat in Q2’24 as compared to...
DALLAS, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Beneficient (NASDAQ: BENF) (“Ben” or the “Company”), a technology-enabled financial services holding company...
SAN DIEGO, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Beam Global, (Nasdaq: BEEM), a leading provider of innovative and sustainable infrastructure...
ATLANTA, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused...
LONDON, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell...
Company to Present Early Non-muscle Invasive Bladder Cancer (NMIBC) Data from Ongoing Phase 1 Trial at a Urologic Oncology Investor...
Contacts Astria: Investor Relations and Media: Elizabeth Higgins investors@astriatx.com Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing...
ALBUQUERQUE, N.M., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Array Technologies (NASDAQ: ARRY) (“Array” or the “Company”), a global leader in...
Net Revenue of $310 million, Net Income of $22 million and Adjusted EBITDA of $40 millionOpened Five New Showrooms in...
PRINCETON, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the...
– Company to Host Conference Call on August 30, 2024, at 1:00 p.m. (BST), 8:00 a.m. (ET) to Discuss Results...
SDK helps developers find and fix accessibility issues before they are visible to the public TUCSON, Ariz., Aug. 7, 2024...
NEW YORK, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Aeries Technology, Inc. (“Aeries” or “the Company”) (Nasdaq: AERT), a global professional...
WILLOW PARK, Texas, Aug. 8, 2024 /PRNewswire/ -- ProFrac Holding Corp. (NASDAQ: ACDC) ("ProFrac", or the "Company") today announced financial...
SEATTLE, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will be presenting at the...
FYARRO® sales of $6.2 million for Q2 2024, a 15% quarter over quarter sales growth Interim analysis of two-thirds of...